Study of Virtual Simulated Resuscitation in Junior Clinicians

Pilot Randomised Controlled Trial of Virtual Patient Simulation Versus In-situ Simulation for Improving Performance in Trauma and Sepsis Resuscitation in Junior Clinicians in the Emergency Department

The investigators seek to examine the impact of virtual patient simulation on junior clinicians' resuscitation skills in an academic emergency department.

Exposure to real life resuscitation cases is opportunistic, with variation in case mix across different junior clinicians. Junior clinicians are closely supervised during resuscitations, with limited independence to make decisions, for patient safety.

High fidelity simulation, such as in-situ mock codes with a high fidelity manikin, is resource intensive. Constraints in facilitator and learner time and manpower reduce the feasibility of holding large numbers of simulations for large numbers of learners, leading to limited breadth of case mix exposure in simulation cases.

Virtual patient simulation may allow greater and more uniform breadth of exposure and allow automated feedback and rapid cycle deliberate practiceacross a wide range of cases, with reduced resource intensiveness, and prepare them to better utilise limited opportunities for resuscitation during real life or high fidelity simulation.

Virtual simulators have been found to be useful for improving skills rather than knowledge or attitudes in health professions education. Such skills include communication, radiograph interpretation, dermatological diagnosis, and cardiac arrest procedures.

What is not known is:

1. Whether going directly to in-situ simulation with a high fidelity manikin is the best learning approach for resuscitation, given its potentially detrimental high cognitive load, compared to going first to virtual patient simulation.
2. Whether the benefits of virtual simulation extend beyond cardiac arrest and to other resuscitation scenarios, such as trauma, sepsis, and others.

The investigators' hypothesis is that in junior clinicians in the emergency department who have received didactic materials in trauma and sepsis resuscitation, proceeding next to learning by virtual patient resuscitation simulation is associated with improved scores in resuscitation performance for trauma and sepsis, as measured by checklists of required actions during observed in-situ simulation with a high-fidelity manikin, compared to proceeding next to learning by team-based in-situ simulation with a high fidelity manikin. This pilot study aims to determine the feasibility of a randomised controlled trial to test the above hypothesis.

Study Overview

• Status: Completed
• Conditions: Education, Medical
• Intervention / Treatment: Other: Virtual simulation; Other: Team based in situ simulation

Detailed Description

Sample size: For a pilot study, a sample size of at 24-50 participants is advisable to be informative regarding population characteristics such as expected means and standard deviation, to facilitate future study, where sample size calculation will target a small standardised effect size of 0.2, where standardised effect size would be the difference in means divided by standard deviation. About 50 junior clinicians are anticipated to rotate through NUH emergency department for at least 3 months in 2022.

Randomisation:

- After informed consent and recruitment, participants will be randomised to virtual simulation versus in-situ simulation groups, through the use of opaque sealed envelopes. The randomisation sequence will be generated by one investigator (A), with block randomisation in varying block sizes, while another investigator (B) will open envelopes to allocate learners to their groups, to maintain allocation concealment.

Interventions:

• Two investigators (C and D) will schedule participants for assigned interventions, namely virtual simulation or team-based in-situ simulation. As team-based in-situ simulation sessions are dispersed across each month, virtual simulation sessions will be matched to in-situ simulation days, to prevent confounding by time from outcome assessment. All interventions will be scheduled after didactic materials for resuscitation have been delivered to learners as part of standard departmental curriculum.
• Virtual simulation group: Participants will log in to the virtual simulation software from home and play 2 cases (1 case of sepsis, 1 case of trauma). Participants are instructed to play each case as many times as personally desired within 70 minutes, to reach the highest score possible in that time. This process is proctored, with participants sharing their screen over video conferencing with two investigators (C and D) to ensure adherence to time limit and cases played.
• Team based in situ simulation group: Faculty observing and debriefing learners at the mock code will be variable and consist of a wide range of NUH emergency department faculty outside of this study, due to logistical constraints in having the same faculty being present consistently in the entire year. The in situ simulation will cover 1 case of sepsis, and 1 case of trauma, with case content matched to the cases in the virtual simulation group, and time matched at 70 minutes.

Outcome assessment:

• Scores obtained based on number of correct actions completed in a timely manner, during simulated resuscitation with a high fidelity manikin around the end of the 3rd month of their posting, as compared to a checklist of required actions derived from expert consensus among NUH emergency department clinicians, and aligned to established international guidelines for resuscitation in sepsis or trauma (e.g. Advanced Trauma Life Support 10th edition).
• Two trained and standardised assistants, playing the roles of one nurse and one doctor, will be present to assist the medical officer, who will take the role of resuscitation team leader.
• Each study participant will be observed and marked on two scenarios: one scenario on major trauma resuscitation, and one scenario on resuscitation of a patient with sepsis. Marking will be performed independently by two investigators (E and F) who will calibrate and standardise their ratings by watching one investigator (A) perform simulated resuscitation at different levels of competence, and using that as a stimulus to calibrate their ratings.
• All assistants and assessors doing marking will be blinded to participant allocation, and will not be involved in team based in situ simulated resuscitation during the study period.

Other data collection:

• Learner demographic data, level of post graduate experience generally and in emergency medicine, and views regarding assigned intervention (i.e. Kirkpatrick level of reaction), will be collected via an online questionnaire.
• The following virtual simulation metrics will be automatically captured: Number of attempts for each unique case, time spent on each attempt, scores obtained during each attempt as marked by a virtual patient simulator

Data analysis:

- Descriptive statistics of the following will be tabulated:

• Baseline characteristics of learners in each group, to determine effectiveness of randomisation
• Learner reaction data, to determine extent of acceptability of virtual patient simulation based on learner perception
• Mean, median, and measures of spread (either standard deviationor interquartile range, depending on whether data is normally distributed) of scores obtained

Analysis for associations:

• Primary outcome: Association between exposure to virtual patient simulation (categorical variable) and marks obtained during observed in-situ resuscitation using a high fidelity manikin (likely to be a continuous variable with normal distribution, and this pilot study would help to determine if that is true), as measured by number of correct actions completed on a checklist derived from local expert consensus, rated by two independent observers (Investigators E and F) with statistical testing using a 2-tailed student t-test.

  --> Interobserver agreement will be measured using intra class correlation

• The investigators acknowledge that as a pilot, the analyses are unlikely to be adequately powered. Nonetheless, understanding the distribution of marks in each group, including mean/median/measures of variance, would be useful for planning further study.

• Study Type: Interventional
• Enrollment (Actual): 40
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Singapore
  • Singapore, Singapore, 119074
    • National University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 99 years (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Junior doctors scheduled to rotate through NUH emergency department for at least 3 months

Exclusion Criteria:

• Pregnant women will be excluded from the study as the study procedures do involve additional exposure to fellow healthcare workers, with the associated risk of COVID transmission, while there is no direct benefit in terms of generalisable knowledge about pregnancy or the fetus.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Virtual simulation; - Virtual simulation group: Participants will log in to the virtual simulation software from home and play 2 cases (1 case of sepsis, 1 case of trauma). Learners are instructed to play each case as many times as they like within 70 minutes, to reach the highest score possible in that time. This process is proctored, with participants sharing their screen over video conferencing with study team members (JCL or LZY) to ensure adherence to time limit and cases played.	Other: Virtual simulation; Virtual simulation using Full-Code, a virtual simulation software with a bank of emergency medicine cases
Active Comparator: Team based in situ simulation; - Team based in situ simulation group: Faculty observing and debriefing learners at the mock code will be variable and consist of a wide range of NUH emergency department faculty outside of this study, due to logistical constraints in having the same faculty being present consistently in the entire year. The in situ simulation will cover 1 case of sepsis, and 1 case of trauma, with case content matched to the cases in the virtual simulation group, and time matched at 70 minutes.	Other: Team based in situ simulation; In situ simulation, using a high fidelity manikin in the critical care area of the emergency department, with team members consisting of multiple junior doctors and nurses, facilitated by senior emergency medicine doctors and nurses.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Score obtained in outcome assessment simulation	Participants will be assessed by 2 independent assessors using a standardised checklist during simulation with a high fidelity manikin and standardised assistants in two scenarios: trauma, and sepsis	At end of 3rd month of junior clinicians' emergency medicine rotation

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Learner satisfaction	Participants report their level of satisfaction with the intervention through an online questionnaire.	Within one week after completion of assigned intervention

Collaborators and Investigators

• Sponsor: National University Hospital, Singapore
• Investigators: Principal Investigator: Matthew JW Low, MBBS, National University Hospital, Singapore

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2022
• Primary Completion (Actual): December 2, 2022
• Study Completion (Actual): February 10, 2023

Study Registration Dates

• First Submitted: December 16, 2021
• First Submitted That Met QC Criteria: January 9, 2022
• First Posted (Actual): January 21, 2022

Study Record Updates

• Last Update Posted (Estimate): March 3, 2023
• Last Update Submitted That Met QC Criteria: March 2, 2023
• Last Verified: January 1, 2023

More Information

Terms related to this study

• Other Study ID Numbers: DSRB 2021/00542

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No